NEW YORK (GenomeWeb) – Invivoscribe said today that it has inked a long-term collaboration with Illumina to develop and commercialize in vitro diagnostic assays for Illumina's MiSeqDx next-generation sequencing platform.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.
This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.